Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cancer Research Technology and AstraZeneca extend cancer metabolism alliance

March 11, 2013

Maximum tolerated dose defined in CH-5132799 study

March 8, 2013

Genentech presents phase I results for GDC-0068

March 8, 2013

Cylene and TetraGene enter exclusive worldwide agreement for anticancer candidate

March 8, 2013

Novogen signs memorandum of understanding with The Ingham Institute

March 8, 2013

Phase II study of palifosfamide in incurable germ cell tumors begins

March 8, 2013

Senesco takes steps to accelerate enrollment in phase Ib/IIa study of anticancer candidate

March 8, 2013

FDA approves use of two Dako assays with Genentech's new breast cancer medicine

March 7, 2013

Nymox provides update on U.S. phase II trial in early-stage prostate cancer

March 7, 2013

Clinical results reported for ATU-027 in patients with advanced solid tumors

March 7, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...